|
Aug 8
|
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
|
|
Aug 7
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Aug 6
|
Bio-Techne beats quarterly estimates, flags tariff uncertainty for customers
|
|
Aug 5
|
Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy
|
|
Aug 1
|
Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.
|
|
Aug 1
|
Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y
|
|
Jul 31
|
Danaher Appoints Jonathan Leiken as General Counsel
|
|
Jul 30
|
Aldevron Launches New Innovation Center in Waltham, MA
|
|
Jul 30
|
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic
|
|
Jul 30
|
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
|
|
Jul 30
|
Jim Cramer on Danaher: “I Think We’ve Finally Reached the Tipping Point”
|
|
Jul 29
|
Danaher Corporation (DHR): Maybe It Can Be Great Again, Says Jim Cramer
|
|
Jul 29
|
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
|
|
Jul 29
|
Where this large cap portfolio manager see opportunity now
|
|
Jul 29
|
5 Revealing Analyst Questions From Danaher’s Q2 Earnings Call
|
|
Jul 28
|
Veralto lifts annual profit forecast on water treatment demand
|
|
Jul 28
|
International Markets and Danaher (DHR): A Deep Dive for Investors
|
|
Jul 26
|
Danaher Corporation (DHR)’s Been A Disaster, Says Jim Cramer
|
|
Jul 25
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jul 25
|
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
|